Development of written information for antiretroviral therapy: Comprehension in a Tanzanian population

Pharmacy World and Science

Volumn 29, Issue 3, 2007, Pages 173-182

  Mwingira, Betty ^a   Dowse, Ros ^a  

^a RHODES UNIVERSITY   (South Africa)

Author keywords

Acceptability; Antiretrovirals; Comprehension; Patient communication; Patient information leaflet; Pictograms; PIL; Tanzania; Written information

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; STAVUDINE;

ADULT; AGED; ARTICLE; COMPREHENSION; DEVELOPMENT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INTERPERSONAL COMMUNICATION; INTERVIEW; MALE; OPEN ENDED QUESTIONNAIRE; PATIENT INFORMATION; POPULATION; STRUCTURED QUESTIONNAIRE; TANZANIA;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-RETROVIRAL AGENTS; COMPREHENSION; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; LANGUAGE; MALE; MIDDLE AGED; PAMPHLETS; PATIENT EDUCATION; TANZANIA;

EID: 34249911720     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-006-9056-0     Document Type: Article

References (29)

1. Coulter A. Evidence based patient information. BMJ 1998; 317:225-6.
2. Howard J., Wildman K., Blain J., Wills S., Brown D. The importance of drug information from a patient perspective. J Soc Admin Pharm 1999; 16:115-26.
3. Koo M.M., Krass I., Aslani P. Patient characteristics influencing evaluation of written medicine information: lessons for patient education. Ann Pharmacother 2005; 39:1434-40
4. Mansoor L., Dowse R. Effect of pictograms on readability of patient information materials. Ann Pharmacother 2003; 37:1003-9.
5. Dowse R, Ehlers MS. Medicine labels incorporating pictograms: do they influence understanding and adherence? Patient Educ Couns 2005; 58:63-70.
6. Schaafsma ES, Raynor DK, de Jong-van den Berg LTW. Acessing medication information by ethnic minorities: barriers and possible solutions. Pharm World Sci 2003; 25:185-90.
7. Buck ML. Providing patients with written medication information. Ann Pharmacother 1998; 32:962-9.
8. Doak CC, Doak LG, Root JH. Teaching patients with low-literacy skills. Philadelphia (JB): Lippincott Co; 1996. ISBN 0-397-55161-4
9. Morris LA, Aikin KJ. The pharmacokinetics of patient communications. Drug Inf J 2001; 35:509-27.
10. Kenny T, Wilson RG, Purves IN, Clark J, Newton LD, Newton DP, Moseley DV. A PIL for every ill? Patient information leaflets (PILs):a review of past, present and future use. Fam Pract 1998; 15:471-9.
11. Bradley B, Singleton M, Li Wan Po A. Readability of patient information leaflets on over-the-counter (OTC) medicines. J Clin Pharm Ther 1994; 19:7-15.
12. Davis TC, Mayeaux EJ, Fredrickson D, Bocchini JA, Jackson RH, Murphy PW. Reading ability of parents compared with reading level of pediatric patient education materials. Pediatrics 1994; 98:460-4.
13. Institute of Medicine Committee on Health Literacy. Health literacy: a prescription to end confusion. Washington, DC: The National Academies Press; 2004. ISBN 0-309-52926-3
14. Gustafsson J, Kälvemark S, Nilsson G, Nilsson LG. Patient information leaflets - patients' comprehension of information about interactions and contraindications. Pharm World Sci 2005; 27:35-40.
15. Davis TC, Wolf MS. Health literacy: implications for family medicine. Fam Med 2004; 36:595-8.
16. UNESCO Institute for Statistics, Literacy Statistics (August 2005 assessment). http://www.uis.unesco.org/ev.php?URL_ID=5204&URL_DO= DO_TOPIC&URL_SECTION=201(November 17, 2005)
17. UNAIDS/WHO AIDS epidemic update: December 2005. http://www.unaids.org/ Epi2005/doc/report_pdf.html (November 23,2005)
18. Tanzania Care. HIV/AIDS in Tanzania. (Fact sheet) October 2005. http://tanzaniacare.org/download/fact_sheets/AIDS_in_Tanzania.pdf 4 (November 21, 2005)
19. Smith SR, Rublein JC, Marcus C, Penick Brock T, Chesney MA. A medication self-management program to improve adherence to HIV therapy regimens. Patient Educ Couns 2003; 50:187-99.
20. Sless D, Wiseman R. Writing about medicines for people, 2nd ed. Australian Government Publishing Service: Canberra; 1997.
21. Dickinson D, Raynor DK, Duman M. Patient education leaflets for medicines: using consumer testing to determine the most effective design. Pat Educ Couns 2001; 43:147-59.
22. Koo MM, Krass I, Aslani P.Factors influencing consumer use of written drug information. Ann Pharmacother 2003; 37:259-67.
23. Raynor DK. Writing patient information-A pharmacist's guide. Pharm J 1992; 249:180-2.
24. Medicines Control Council, Department of Health, Republic of South Africa. Guidelines on the requirements for patient information leaflets. Document 2.14MAY04V2:May 2004
25. USP DI. Vol. II 2000. Advice for the patient. Drug information in lay language. 20th ed. Englewood: Micromedex, Inc.; 2000
26. Dowse R, Ehlers MS. The evaluation of pharmaceutical pictograms in a low-literate South African population. Pat Educ Couns 2001; 45:87-99.
27. Mwingira B. Written medicines information for antiretroviral therapy. [MSc Dissertation]. Grahamstown: B Mwingira; 2005
28. Fry E. Fry's readability graph: Clarification, validity, and extension to level 17. J Reading 1977; 21:242-52.
29. Sojourner R, Wogalter M. The influence of pictorials on the comprehension and recall of pharmaceutical safety and warning information. Int J Cogn Ergon 1998; 2:93-106.